We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Eye Care

Journal Scan / Research · August 16, 2022

Financial Incentives for Anti-VEGF Therapy for Diabetic Retinopathy

American Journal of Ophthalmology


Additional Info

Disclosure statements are available on the authors' profiles:

American Journal of Ophthalmology
A Caveat about Financial Incentives for Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Retinopathy
Am J Ophthalmol 2022 Jul 25;[EPub Ahead of Print], BK Young, M Hwang, MW Johnson, CG Besirli, TJ Wubben

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading